ArticleJournal of Cancer2024

Discovery of a novel ROS-based signature for predicting prognosis and immunosuppressive tumor microenvironment in lung adenocarcinoma.

Yufeng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.